COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20211012052735N1


Column Value
Trial registration number IRCT20211012052735N1
Full text link
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Dr Mehraban Sadeghi

Contact
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

j_saffari@yahoo.com

Registration date
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-11-05

Recruitment status
Last imported at : Dec. 11, 2021, 2:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

single-center

Study aim
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Patients are to be free of any underlying disorders. Patients are to be free of any kidney (creatinine test), liver (liver and LFT tests), and heart damages. The age of inclusion in the study is to be between 20-50 years Nasopharyngeal RT-PCR test sample is to be positive Diagnosed with lung damages through CT scan Have no history of viral infections with hepatitis and AIDS Have not had received recombinant treatments Have not had G6PD enzyme defect O2Saturation of patients is to be less or equal to 85

Exclusion criteria
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Pregnant women and women who are planning to become pregnant Breastfeeding women People with a history of allergies to methylene blue People with a BMI above 30 People with kidney, heart, lung disorders

Number of arms
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Shahre-kord University of Medical Sciences

Inclusion age min
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

20

Inclusion age max
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

50

Countries
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Severe/critical disease at enrollment

Severity scale
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

7: Severe/critical disease at enrollment

Total sample size
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

60

primary outcome
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blood O2 saturation

Notes
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 1/Phase 2

Arms
Last imported at : Nov. 6, 2021, 2:33 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 797, "treatment_name": "Methylene blue", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]